A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lance Leopold, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ordensklinikum Linz Gmbh Elisabethinen
Linz, Austria
- Universitaire Ziekenhuis Leuven - Gasthuisberg
Leuven, Belgium
- Providence Health
Vancouver, British Columbia, Canada
- Universitatsklinikum Halle (saale)
Halle, Germany
- University Medical Centre Hamburg-Eppendorf Centre of Oncology
Hamburg, Germany
- University Hospital Mannheim
Mannheim, Germany
- University Hospital of West Attica - Attikon
Chaïdári, Greece
- Hadassah Hebrew University Medical Center Ein Karem Hadassah
Jerusalem, Israel
- Azienda Policlinico Vittorio Emanuele
Catania, Italy
- Azienda Ospedaliera Bianchi-Melacrino-Morelli Ospedali Riuniti
Reggio Calabria, Italy
- Aou San Giovanni Di Dio E Ruggi
Salerno, Italy
- Hospital Universitario Virgen de Las Nieves
Granada, Spain
- Hospital Universitario Ramon Y Cajal
Madrid, Spain
- City of Hope National Medical Center
Duarte, California, United States
- Anschutz Cancer Pavilion-University of Colorado
Aurora, Colorado, United States
- Parkview Cancer Institute
Fort Wayne, Indiana, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Temple University Department of Thoracic Medicine and Surgery
Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Texas Oncology San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Mar 2021
- Primary completion
- 11 May 2026
- Completion
- 11 May 2026
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 18
- Registry id
- NCT04640025
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.